Reply to: Comments on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients"
Int J Cancer
.
2024 Apr 1;154(7):1326-1327.
doi: 10.1002/ijc.34797.
Epub 2024 Jan 11.
Authors
Mi Na Kim
1
2
3
,
Xuehong Zhang
4
5
,
Sang Hoon Ahn
1
2
3
Affiliations
1
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
2
Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.
3
Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea.
4
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
5
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
PMID:
38212637
DOI:
10.1002/ijc.34797
No abstract available
Publication types
Letter
MeSH terms
Carcinoma, Hepatocellular*
Diabetes Mellitus*
Hepatitis, Viral, Human*
Humans
Liver Neoplasms*
Non-alcoholic Fatty Liver Disease*
Risk Factors